Debussche L - Search Results

1

p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.

Wasylyk C, Salvi R, Argentini M, Dureuil C, Delumeau I, Abecassis J, Debussche L, Wasylyk B. Wasylyk C, et al. Among authors: debussche l. Oncogene. 1999 Mar 18;18(11):1921-34. doi: 10.1038/sj.onc.1202528. Oncogene. 1999. PMID: 10208414

2

Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments.

Caron de Fromentel C, Gruel N, Venot C, Debussche L, Conseiller E, Dureuil C, Teillaud JL, Tocque B, Bracco L. Caron de Fromentel C, et al. Among authors: debussche l. Oncogene. 1999 Jan 14;18(2):551-7. doi: 10.1038/sj.onc.1202338. Oncogene. 1999. PMID: 9927212

3

MBP1: a novel mutant p53-specific protein partner with oncogenic properties.

Gallagher WM, Argentini M, Sierra V, Bracco L, Debussche L, Conseiller E. Gallagher WM, et al. Among authors: debussche l. Oncogene. 1999 Jun 17;18(24):3608-16. doi: 10.1038/sj.onc.1202937. Oncogene. 1999. PMID: 10380882

4

Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules.

Wasylyk C, Zheng H, Castell C, Debussche L, Multon MC, Wasylyk B. Wasylyk C, et al. Among authors: debussche l. Cancer Res. 2008 Mar 1;68(5):1275-83. doi: 10.1158/0008-5472.CAN-07-2674. Cancer Res. 2008. PMID: 18316589

5

The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L. Venot C, et al. Among authors: debussche l. EMBO J. 1998 Aug 17;17(16):4668-79. doi: 10.1093/emboj/17.16.4668. EMBO J. 1998. PMID: 9707426 Free PMC article.

6

Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains.

Venot C, Maratrat M, Sierra V, Conseiller E, Debussche L. Venot C, et al. Among authors: debussche l. Oncogene. 1999 Apr 8;18(14):2405-10. doi: 10.1038/sj.onc.1202539. Oncogene. 1999. PMID: 10327062

7

A tumor specific single chain antibody dependent gene expression system.

Mary MN, Venot C, Caron de Fromentel C, Debussche L, Conseiller E, Cochet O, Gruel N, Teillaud JL, Schweighoffer F, Tocque B, Bracco L. Mary MN, et al. Among authors: debussche l. Oncogene. 1999 Jan 14;18(2):559-64. doi: 10.1038/sj.onc.1202377. Oncogene. 1999. PMID: 9927213

8

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.

Hata AN, Rowley S, Archibald HL, Gomez-Caraballo M, Siddiqui FM, Ji F, Jung J, Light M, Lee JS, Debussche L, Sidhu S, Sadreyev RI, Watters J, Engelman JA. Hata AN, et al. Among authors: debussche l. Oncogene. 2017 Nov 23;36(47):6581-6591. doi: 10.1038/onc.2017.258. Epub 2017 Aug 7. Oncogene. 2017. PMID: 28783173 Free PMC article.

9

A Ras-GTPase-activating protein SH3-domain-binding protein.

Parker F, Maurier F, Delumeau I, Duchesne M, Faucher D, Debussche L, Dugue A, Schweighoffer F, Tocque B. Parker F, et al. Among authors: debussche l. Mol Cell Biol. 1996 Jun;16(6):2561-9. doi: 10.1128/MCB.16.6.2561. Mol Cell Biol. 1996. PMID: 8649363 Free PMC article.

10

P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis.

Mahfoudhi E, Lordier L, Marty C, Pan J, Roy A, Roy L, Rameau P, Abbes S, Debili N, Raslova H, Chang Y, Debussche L, Vainchenker W, Plo I. Mahfoudhi E, et al. Among authors: debussche l. Oncotarget. 2016 May 31;7(22):31980-92. doi: 10.18632/oncotarget.7881. Oncotarget. 2016. PMID: 26959882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters